modeling
In Brief This Week: Epitopoietic Research Corporation, SEngine Precision Medicine
News items for the week of July 25, 2022.
Known Medicine, Duke University Partner to Study Predictive Platform for Lung Cancer Drug Response
The collaboration will evaluate the Known Medicine ODIN platform's ability to predict lung cancer patients' response to treatment.
BMO Financial Group's $2M Gift to Support McGill University Precision Oncology Program
The funds will be used to develop organoids that can personalize treatments for cancer patients as well as other tools and resources.
After a promising pilot study, researchers at the University of Helsinki are starting a larger investigation of patients' response to drugs selected via this method.
Known Medicine Closes $7.2M Seed Funding Round
The Utah-based firm will use the funds to advance its 3D organoid modeling technology to help with the development and delivery of precision medicines.